Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NLRP3 licenses NLRP11 for inflammasome activation in human macrophages.
Gangopadhyay A, Devi S, Tenguria S, Carriere J, Nguyen H, Jäger E, Khatri H, Chu LH, Ratsimandresy RA, Dorfleutner A, Stehlik C. Gangopadhyay A, et al. Among authors: chu lh. Nat Immunol. 2022 Jun;23(6):892-903. doi: 10.1038/s41590-022-01220-3. Epub 2022 May 27. Nat Immunol. 2022. PMID: 35624206 Free PMC article.
Inhibiting the inflammasome: one domain at a time.
Dorfleutner A, Chu L, Stehlik C. Dorfleutner A, et al. Immunol Rev. 2015 May;265(1):205-16. doi: 10.1111/imr.12290. Immunol Rev. 2015. PMID: 25879295 Free PMC article. Review.
The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation.
Ratsimandresy RA, Chu LH, Khare S, de Almeida L, Gangopadhyay A, Indramohan M, Misharin AV, Greaves DR, Perlman H, Dorfleutner A, Stehlik C. Ratsimandresy RA, et al. Among authors: chu lh. Nat Commun. 2017 Jun 5;8:15556. doi: 10.1038/ncomms15556. Nat Commun. 2017. PMID: 28580931 Free PMC article.
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.
Kanegane H, Endo A, Okada S, Ohnishi H, Ishimura M, Nishikomori R, Imai K, Nonoyama S, Muramatsu H, Wada T, Kuga A, Sakamoto K, Russo-Schwarzbaum S, Chu LH, McCoy B, Li Z, Yel L. Kanegane H, et al. Among authors: chu lh. Immunother Adv. 2024 Mar 1;4(1):ltae001. doi: 10.1093/immadv/ltae001. eCollection 2024. Immunother Adv. 2024. PMID: 38511087 Free PMC article.
CELLULAR RNA INTERACTS WITH MAVS TO PROMOTE ANTIVIRAL SIGNALING.
Gokhale NS, Somfleth K, Thompson MG, Sam RK, Marciniak DM, Chu LH, Park M, Dvorkin S, Oberst A, Horner SM, Ong SE, Gale M Jr, Savan R. Gokhale NS, et al. Among authors: chu lh. bioRxiv [Preprint]. 2023 Sep 25:2023.09.25.559083. doi: 10.1101/2023.09.25.559083. bioRxiv. 2023. PMID: 37808873 Free PMC article. Preprint.
49 results